Digital health
Metabolic and immune health
Healthy Living & Work

Webinar Personalised Health: From science to market

Are you interested in developing evidence-based personalised health applications in your business to contribute to a healthier society? Get inspired by the experience of companies that already innovate with us. Join our interactive webinar for the latest scientific based developments in personalised health.

15:00 - (CET)

Let's prevent or revert lifestyle-related diseases

Public health is declining due to the increase in chronic lifestyle-related diseases. These diseases can be prevented and even reversed. However, this requires a sustainable behaviour change to be successful.

Within the Personalised Health research programme, TNO has developed new knowledge, innovative methodologies and tools to provide personalised health advice. The measurement of so-called phenotypic flexibility (challenge tests) was pioneered by TNO and still constitutes the starting point for personalised health advice. But it’s not just biology that matters. Psychology, behaviour and social context are also taken into account in order to develop the best tools and interventions for the individual. TNO’s vision on public health improvement is that a systems approach is needed, from measuring health to supporting healthy behaviour.

personalised-health (2)
Personalised health

Putting personalised health into practice

Together with various partners, we are committed to translating our acquired knowledge into applications and to putting personalised health into practice. We help partners and companies with:

  • Sense: Selecting the right (objective) and science-based measurements by assessing a person’s health status from a 360 degrees perspective;
  • Reason: Making use of a science-based model that translates data from a person’s situation into the optimal personalised lifestyle intervention and;
  • Act: Based on a person’s personality, behaviour, preferences and circumstances determine the right lifestyle support for a sustainable behaviour change to maintain health and prevent or revert lifestyle-related diseases.

If you want to learn how, we warmly invite you to join our interactive webinar for the latest scientific insights in personalised health and get inspired by the experience of companies that already innovate with us.

This webinar answers these questions:

  1. What are the latest scientific developments for putting personalised health into practice?
  2. How to come to evidence-based personalised health products and services?
  3. What are the latest trends and developments in the market of personalised health?
Suzan Wopereis

“Personalised health and lifestyle interventions taking into account your own biology, phenotypic flexibility, personality and preferences is there to stay! As applied research organisation, we help other parties how to bring these personalised health innovations, scientific understanding and consumer engagement into applications and products that help create a healthy society.”

Suzan Wopereis

Principal Scientist, TNO



By webinar host Nard Clabbers, thought leader in personalised nutrition.


  • Sarah Berry | Opening lecture: Personalised nutrition for metabolic health
  • Suzan Wopereis, TNO | From science to evidence based personalised health applications and services.


Three companies pitch their (future) product/service:

  • MixMasters: Tom Geleijnse (CEO)
  • Ancora Health: Sridhar Kumaraswamy (CEO)
  • J&J Consumer Health: Gabriele Ronnett, PhD, MD (Head of Nutritional Therapeutics & Systems Health) | Let’s take it personally
  • Round table discussion & questions

Keynote: In pursuit of Personalised nutrition - the solution on our plates.

Mariette Abrahams, PhD, MBA (CEO Qina).

Wrap up

Nard Clabbers.


  • Nard-Clabbers

    Nard Clabbers

    Thought leader Personalised Nutrition

  • Sarah-Berry

    Sarah Berry

    Scientist and lecturer in nutritional sciences

  • Suzan-Wopereis

    Suzan Wopereis

    Principal Scientist, TNO

  • Sridhar-Kumaraswamy

    Sridhar Kumaraswamy

    CEO, Ancora Health

  • Tom-Geleijnse2

    Tom Geleijnse

    CEO, MixMasters

  • Gabriele-Ronnet

    Gabriele Ronnett

    Head Nutritional Therapeutics & Systems Health, Johnson & Johnson Consumer Health

  • Mariette-Abrahams

    Mariette Abrahams

    CEO, Qina

Watch the webinar

  • The webinar takes place on 21 March 2023 from 15:00-16:30 CET.
  • Not able to join live? We will share the recording afterwards.
  • This webinar will be held in English.
Sarah Berry

"My research focuses on the influence of dietary components on cardiometabolic disease risk; personalised nutrition, postprandial lipid metabolism and food and fat structure."

Sarah Berry

Scientist and lecturer in nutritional sciences

Mariette-Abrahams (2)

"In this next phase, we will see the personlised nutrition industry coming of age. It is not only exciting, it will actually make a difference."

Mariette Abrahams

CEO, Qina

Get inspired

12 resultaten, getoond 1 - 5

Public Private Partnership supports intestinal health in early life

28 February 2023

Public Private Partnership Fontanelle works on the solutions that contribute to long-term effects on (gut) health through the development of an integrated approach of in vitro, ex vivo and AI models to test the potential health benefits of specialised nutrition for infants and young piglets.

Personalised food conveniently delivered to your home

23 January 2023

MixMasters develops, manufactures, and packages personalised health food and sports supplements. They try to bring healthy food to their customers in innovative ways and focus mainly on the sports and health industry.

TNO's view of 2030: 50% reduction in lifestyle-related diseases

14 November 2022

We look ahead to 2030 and find out, among other things, how we can offer people a healthy environment and with a healthier lifestyle.

Personalised Lifestyle and Resilience


Behavioural change is the key to curing lifestyle diseases. In short: lifestyle as medicine. Find out more about our innovations and tools.

Cash infusion for photonics-focused biosensor start-up

14 July 2022

Biosensor R&D start-up Delta Diagnostics has received a seed investment from two leading innovators: research organization TNO – The Netherlands Organization for Applied Scientific Research – and PhotonDelta, an ecosystem of photonic chip technology organizations. This investment enables Delta Diagnostics to further develop and validate its biosensor systems in preparation for a Series A investment round later this year.